Skip to content

Clinical trials

Phase 3 Hypogonadism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypogonadism Phase: Phase 3 Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20041
20063
20072
20082
20101
20123
20131
20145
20152
20161
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Repros Therapeutics Inc.7
Eli Lilly and Company3
Antares Pharma Inc.2
Ardana Bioscience Ltd2
Endo USA Inc., a Keenova Therapeutics Company2
AbbVie1
Amneal Pharmaceuticals, LLC1
Clarus Therapeutics, Inc.1
Halozyme Therapeutics1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypogonadism26
Eunuchism2
Prostatic Neoplasms2
Frailty1
Hip Fractures1
Obesity1
Osteoporosis1
Primary Ovarian Insufficiency1
Turner Syndrome1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.